Spring Research Update Meeting 2025: watch again
Our 2025 Spring Research Update Meeting took place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invited guests to an inspiring agenda of some of the most up to date news of our funded research....
Learn more
Ambroxol and Parkinson’s
ASPro-PD, or Ambroxol to Slow Progression in Parkinson’s, is a phase 3 clinical trial looking to assess whether ambroxol, a cough medicine, can slow or stop the progression of Parkinson’s motor symptoms. Contents About the study Led by Professor Anthony Schapira at University College London...
UDCA and Parkinson’s
The UP Study, or UDCA for Parkinson’s Study, was a phase 2 clinical trial which aimed to assess the safety and tolerability of ursodeoxycholic acid (UDCA) in people with Parkinson’s. Contents About the study Led by Professor Oliver Bandmann at the University of Sheffield, this...